Myles Brown

Myles is Director of the Center for Functional Cancer Epigenetics at the Dana-Farber Cancer Institute and the Emil Frei III Professor of Medicine at Harvard Medical School. He obtained his B.S. in Biology from Yale University and his M.D. from the Johns Hopkins University School of Medicine. He completed training in Internal Medicine at the Brigham and Women’s Hospital while doing research with David Livingston at the Dana-Farber. He went on to complete training in Medical Oncology at the Dana-Farber and postdoctoral research with Phillip Sharp at MIT. He subsequently joined the staff of the Dana-Farber and the faculty of Harvard Medical School. From 2002-2010 he served as Chief of the Division of Molecular and Cellular Oncology at the Dana-Farber. In 2010 together with Shirley Liu he founded the Center for Functional Cancer Epigenetics at the Dana-Farber. He was elected to the National Academy of Sciences in 2016 and the American Academy of Arts and Sciences in 2017. Myles’ research is focused on providing a detailed understanding of the factors underlying the hormone dependence of breast and prostate cancers with the goal of developing new therapies and improving outcomes for patients.